A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study

Running, not enrolling

Conditions studied: Lumbosacral Radiculopathy

In brief

This is a long-term, 3-year, follow-up study for patients completing the KS-GIG-001-01 Study

Key facts

Study ID

NCT05613569

Run by

Kolon Life Science

People needed

5

Starts

2022-07-26

Expected to finish

2027-04-30

Last updated by the study team

2024-07-08

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• To be considered eligible to participate in this study, a patient must meet the inclusion criteria listed below:
• Patients that have completed the KS-GIG-001-01 Study and were in the Active Treatment group
• Patients having signed the consent forms for both the KS-GIG-001-01 Study and this Long Term, 3-Year Follow-up Study

You may not qualify if…

• To be eligible for entry into the study, the patient must not meet any of the exclusion criteria listed below:
• Enrollment in another AAV or other gene therapy trial

Where it is running

• Kolon Investigative Site : CenExel JBR — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.